Crystallization and preliminary X-ray characterization of the tetrapyrrole-biosynthetic enzyme porphobilinogen deaminase from Bacillus megaterium
aSchool of Biological Sciences, University of Punjab, New Campus, Lahore 54590, Pakistan, bSchool of Biosciences, University of Kent, Stacey Building, Canterbury, Kent CT2 7NJ, England, and cLaboratory of Protein Crystallography, Centre for Amyloidosis and Acute Phase Proteins, UCL Division of Medicine (Royal Free Campus), Rowland Hill Street, London NW3 2PF, England
*Correspondence e-mail: firstname.lastname@example.org
The enzyme porphobilinogen deaminase (PBGD; hydroxymethylbilane synthase; EC 18.104.22.168) catalyses an early step of the tetrapyrrole-biosynthesis pathway in which four molecules of the monopyrrole porphobilinogen are condensed to form a linear tetrapyrrole. The enzyme possesses a dipyrromethane cofactor which is covalently linked by a thioether bridge to an invariant cysteine residue. Expression in Escherichia coli of a His-tagged form of Bacillus megaterium PBGD permitted the crystallization and preliminary X-ray analysis of the enzyme from this species at high resolution.
The enzyme porphobilinogen deaminase (PBGD), which is also known as hydroxymethylbilane synthase (EC 22.214.171.124), catalyses an early step of the tetrapyrrole-biosynthesis pathway in which four molecules of the monopyrrole porphobilinogen are condensed to form a linear tetrapyrrole, preuroporphyrinogen or hydroxymethylbilane (Fig. 1; Jordan, 1991). Isotopic labelling and single-turnover studies showed that the pyrrole-forming ring A (Fig. 1) is the first to bind to the enzyme, followed by rings B, C and finally D. PBGD is a monomeric protein with a molecular weight in the range 34–44 kDa depending on the species (Jordan, 1991). The enzyme possesses a dipyrromethane cofactor (Fig. 2) which is covalently bound to the enzyme by a thioether linkage involving an invariant cysteine residue (Jordan & Warren, 1987). The cofactor acts as a primer to which four porphobilinogen molecules are attached sequentially prior to cleavage of the link between the cofactor and the first substrate molecule on completion of the reaction. Thus, the cofactor remains covalently attached to the enzyme when the product of the reaction is released.
The X-ray structure of the Arabidopsis thaliana enzyme has recently been solved (PDB entry 4htg ; Roberts et al., 2013); prior to this, structures were available for Escherichia coli PBGD [PDB entries 1pda (Louie et al., 1992, 1996), 1gtk (Helliwell et al., 2003), 1ah5 (Hädener et al., 1999), 1ypn (Helliwell et al., 1998) and 2ypn (Nieh et al., 1999)] and the human enzyme (PDB entries 3eq1 and 3ecr ; Gill et al., 2009; Song et al., 2009). The polypeptide is folded into three domains (1–3), each of approximately the same size. The general architecture of domains 1 and 2 shows a strong resemblance to a number of periplasmic binding proteins. The dipyrromethane cofactor is attached to a loop on domain 3 and is positioned at the mouth of a deep active-site cleft formed between domains 1 and 2.
The Gram-positive bacterium Bacillus megaterium is of great industrial interest since it has many commercial applications in the biotechnological production of numerous substances, including the tetrapyrrole vitamin B12. Here, we report the expression and crystallization of PBGD from B. megaterium in a form that diffracts synchrotron radiation to very high resolution.
The B. megaterium PBGD gene was cloned into the NdeI and BamHI restriction sites of the expression vector pET14b using standard methods and was transformed into Rosetta (DE3) E. coli cells (Novagen). Expression was undertaken using 500 ml cultures, which were grown overnight at 310 K following induction with 0.2 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) at mid-log phase. The cultures were then centrifuged at 5000 rev min−1 for 15 min with a Beckman Coulter Avanti J-26 XP ultracentrifuge using a JLA-8.1000 rotor to obtain the cell pellet. The 3.75 g pellet obtained from a 1 l culture was then resuspended in 25 ml 50 mM Tris–HCl buffer pH 8 and sonicated on ice using an MSI Soniprep 150 instrument. The cell lysate was centrifuged at 12 000 rev min−1 using a Beckman JA-25.50 rotor to separate the cell debris from the supernatant. The clear supernatant was then loaded onto a pre-equilibrated HisTrap HP (GE Healthcare) 1 ml column, allowing the His-tagged PBGD to bind prior to washing the column with binding buffer in order to remove impurities. The enzyme was eluted with a buffer containing 500 mM imidazole and the polyhistidine tag was removed by the addition of thrombin (one unit per milligram of purified protein) followed by overnight incubation at room temperature. The cleaved tag and thrombin were then removed by passing the previously dialysed protein through a HisTrap HP 1 ml column again followed by a HiTrap Benzamidine FF 1 ml column (GE Healthcare). The final yield of purified B. megaterium PBGD was approximately 10–12 mg per litre of cell culture. Curiously, the cells and purified protein had a marked pink colouration, although over a period of several weeks the protein became yellow, presumably owing to slow oxidation of the cofactor.
The purified native PBGD was concentrated to 2.5 mg ml−1 using a Vivaspin centrifugal concentrator and was subjected to screening for crystallization conditions by use of the hanging-drop method with Molecular Dimensions Structure Screens I and II. After about two weeks, yellow crystals appeared in Structure Screen I condition 15 (0.1 M sodium cacodylate pH 6.5, 0.2 M magnesium acetate, 20% PEG 8K) at room temperature (Fig. 3). Subsequent optimization screens revealed that crystals could be obtained reproducibly in 0.1 M sodium cacodylate pH 6.5–6.8, 0.2 M magnesium acetate, 25–30% PEG 8K. Removal of the His tag (as described above) was found to be necessary to obtain crystals of this enzyme. Selected crystals were treated by the addition of glycerol to approximately 40%(v/v) before mounting in loops and flash-cooling with an Oxford Cryosystems cryocooler.
X-ray data collection using station I03 at the Diamond Light Source (DLS, Didcot, England) revealed that the B. megaterium PBGD crystals were of very high diffraction quality (Fig. 4). Using 1° oscillations, 190° of data were collected from a single crystal maintained at a temperature of 100 K using a PILATUS 6M-F detector with an exposure time of 1 s per image (15% transmission) and a crystal-to-detector distance of 268.8 mm. The incident beam had a wavelength of 0.976 Å. Data processing with MOSFLM (Leslie, 2006), SCALA (Evans, 2006) and other programs in the CCP4 suite (Winn et al., 2011) revealed that the crystals belonged to the monoclinic space group P212121, with unit-cell parameters a = 53.3, b = 65.8, c = 97.2 Å. Inspection of the correlation coefficient for half-data-set intensities, as recommended by Karplus & Diederichs (2012) and Evans (2012), suggests that the diffraction data extend to a resolution of dmin = 1.46 Å with an overall Rmerge of 6.1% and an Rmeas of 6.7% (for details, see Table 1). By using the method of Matthews (1968), as implemented by Kantardjieff & Rupp (2003), it was estimated that the crystals contained a single PBGD monomer per crystallographic asymmetric unit with a solvent content of 53%. Structure analysis by use of the molecular-replacement program MOLREP (Vagin & Teplyakov, 2010) with E. coli PBGD (47% identity; PDB entry 1pda ; Louie et al., 1992) as the search model was successful and refinement of the B. megaterium PBGD structure is currently in progress using this high-resolution data set.
‡Rmeas = N(hkl)-1]}1/2, where 〈I(hkl)〉 is the mean intensity of the N(hkl) observations Ii(hkl) of each unique reflection hkl after scaling.
We gratefully acknowledge the Pakistan Higher Education Commission for a scholarship to NA. We acknowledge the Diamond Light Source (DLS, UK) for beam time and travel support (award No. MX-7131). We thank Dr Graham Taylor [Centre for Amyloidosis and Acute Phase Proteins, UCL Division of Medicine (Royal Free Campus)] for assistance with mass spectrometry.
Evans, P. (2006). Acta Cryst. D62, 72–82. Web of Science CrossRef CAS IUCr Journals
Evans, P. (2012). Science, 336, 986–987. Web of Science CrossRef CAS PubMed
Gill, R., Kolstoe, S. E., Mohammed, F., Al D-Bass, A., Mosely, J. E., Sarwar, M., Cooper, J. B., Wood, S. P. & Shoolingin-Jordan, P. M. (2009). Biochem. J. 420, 17–25. Web of Science CrossRef PubMed CAS
Hädener, A., Matzinger, P. K., Battersby, A. R., McSweeney, S., Thompson, A. W., Hammersley, A. P., Harrop, S. J., Cassetta, A., Deacon, A., Hunter, W. N., Nieh, Y. P., Raftery, J., Hunter, N. & Helliwell, J. R. (1999). Acta Cryst. D55, 631–643. Web of Science CrossRef IUCr Journals
Helliwell, J. R., Nieh, Y. P., Cassetta, A., Habash, J., Carr, P. D., Ursby, T., Wulff, M., Thompson, A. W., Niemann, A. C. & Haedener, A. (1998). J. Chem. Soc., Faraday Trans. 94, 2615–2622.
Helliwell, J. R., Nieh, Y. P., Habash, J., Faulder, P. F., Raftery, J., Cianci, M., Wulff, M. & Hadener, A. (2003). Faraday Discuss. 122, 131–144. Web of Science CrossRef PubMed CAS
Jordan, P. M. (1991). New Comprehensive Biochemistry, Vol. 19, edited by P. M. Jordan, pp. 1–66. Amsterdam: Elsevier. doi:10.1016/S0167-7306(08)60108-8.
Jordan, P. M. & Warren, M. J. (1987). FEBS Lett. 225, 87–92. CrossRef CAS PubMed Web of Science
Kantardjieff, K. A. & Rupp, B. (2003). Protein Sci. 12, 1865–1871. Web of Science CrossRef PubMed CAS
Karplus, P. A. & Diederichs, K. (2012). Science, 336, 1030–1033. Web of Science CrossRef CAS PubMed
Leslie, A. G. W. (2006). Acta Cryst. D62, 48–57. Web of Science CrossRef CAS IUCr Journals
Louie, G. V., Brownlie, P. D., Lambert, R., Cooper, J. B., Blundell, T. L., Wood, S. P., Malashkevich, V. N., Hädener, A., Warren, M. J. & Shoolingin-Jordan, P. M. (1996). Proteins, 25, 48–78. CrossRef CAS PubMed Web of Science
Louie, G. V., Brownlie, P. D., Lambert, R., Cooper, J. B., Blundell, T. L., Wood, S. P., Warren, M. J., Woodcock, S. C. & Jordan, P. M. (1992). Nature (London), 359, 33–39. CrossRef PubMed CAS Web of Science
Matthews, B. W. (1968). J. Mol. Biol. 33, 491–497. CrossRef CAS PubMed Web of Science
Nieh, Y. P., Raftery, J., Weisgerber, S., Habash, J., Schotte, F., Ursby, T., Wulff, M., Hädener, A., Campbell, J. W., Hao, Q. & Helliwell, J. R. (1999). J. Synchrotron Rad. 6, 995–1006. Web of Science CrossRef CAS IUCr Journals
Roberts, A., Gill, R., Hussey, R. J., Mikolajek, H., Erskine, P. T., Cooper, J. B., Wood, S. P., Chrystal, E. J. T. & Shoolingin-Jordan, P. M. (2013). Acta Cryst. D69, 471–485. Web of Science CrossRef CAS IUCr Journals
Song, G., Li, Y., Cheng, C., Zhao, Y., Gao, A., Zhang, R., Joachimiak, A., Shaw, N. & Liu, Z.-J. (2009). FASEB J. 23, 396–404. Web of Science CrossRef PubMed CAS
Vagin, A. & Teplyakov, A. (2010). Acta Cryst. D66, 22–25. Web of Science CrossRef CAS IUCr Journals
Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242. Web of Science CrossRef CAS IUCr Journals
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.